The Q(u)ALYfying Hand: Health Economics and Medicine in the Shaping of Swedish Markets for Subsidized Pharmaceuticals

The Q(u)ALYfying hand: health economies and medicine in the shaping of Swedish markets for subsidized pharmaceuticals

[1]  C. F. Phillips Industrial Market Structure and Economic Performance , 1971 .

[2]  Jon Dorling,et al.  THE STRUCTURE OF SCIENTIFIC INFERENCE* , 1975, The British Journal for the Philosophy of Science.

[3]  S. Wilson Methods for the economic evaluation of health care programmes , 1987 .

[4]  Donna Harawy Situated Knowledges: The Science Question in Feminism and the Privilege of Partial Perspective , 2022, Philosophical Literary Journal Logos.

[5]  T. Pinch,et al.  Health and efficiency : a sociology of health economics , 1989 .

[6]  Marc Berg,et al.  Rationalizing Medical Work: Decision-support Techniques and Medical Practices , 2022 .

[7]  M. Callon Introduction: The Embeddedness of Economic Markets in Economics , 1998 .

[8]  S. Macstravic Marketing myopia. , 1998, The Healthcare Forum journal.

[9]  Erik Nord,et al.  Cost-Value Analysis in Health Care: Making Sense out of QALYS , 1999 .

[10]  A. Mol Ontological Politics. A Word and Some Questions , 1999 .

[11]  L. Thevenot,et al.  Organized Complexity , 2001 .

[12]  J. Overhage,et al.  Sorting Things Out: Classification and Its Consequences , 2001, Annals of Internal Medicine.

[13]  Brian Rappert,et al.  The Distribution and Resolution of the Ambiguities of Technology, or Why Bobby Can't Spray , 2001 .

[14]  John Law,et al.  Aircraft Stories: Decentering the Object in Technoscience , 2002 .

[15]  M. Callon,et al.  The economy of qualities , 2002 .

[16]  J. Goodwin,et al.  BRINGING THE PATIENT BACK IN , 2002, International Journal of Technology Assessment in Health Care.

[17]  J. Law,et al.  Economics as interference , 2002 .

[18]  Don Slater,et al.  From calculation to alienation: disentangling economic abstractions , 2002 .

[19]  Alberto Cambrosio,et al.  Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine , 2003 .

[20]  [All proton pump inhibitors are equally efficacious in standard dosages]. , 2003, Lakartidningen.

[21]  A. Mol The Body Multiple: Ontology in Medical Practice , 2003 .

[22]  Ett läkemedels öde – dumpning i en politisk soptunna , 2003 .

[23]  Den där marknaden: Utbyten, normer och bilder , 2004 .

[24]  M. Callon,et al.  Economic markets as calculative collective devices , 2005 .

[25]  M. Callon,et al.  Peripheral Vision , 2005 .

[26]  E. Sjögren,et al.  Reasonable drugs : making decisions with ambiguous knowledge , 2006 .

[27]  Claes-Fredrik Helgesson,et al.  Multiple versions of markets: Multiplicity and performativity in market practice , 2006 .

[28]  Victoria E. Bonnell The Purchase of Intimacy , 2007 .

[29]  D. MacKenzie,et al.  Do Economists Make Markets?: On the Performativity of Economics , 2007 .